Skip to main content

Month: September 2024

Verizon to support Florida and Georgia communities affected by Hurricane Helene Call/Text/Data usage incurred by customers in hardest hit counties will be waived from Sept. 26-Oct. 5

For media: Regular updates can be found here. What you need to know:Verizon to waive domestic call, text, and data usage for postpaid consumer, small business customers,* and Verizon Prepaid customers impacted by the storm in parts of Florida and Georgia from Sept. 26-Oct. 5, 2024. For prepaid customers using Straight Talk, Tracfone, Total Wireless, Simple Mobile, Walmart Family Mobile, Net10, GoSmart, and Page Plus, we will extend service end dates to Oct. 5, 2024. With year-round preparedness, hardened network infrastructure, and an extensive fleet of mobile assets, Verizon’s networks are primed for Hurricane Helene.ALPHARETTA, Ga., Sept. 26, 2024 (GLOBE NEWSWIRE) — To help residents in Florida and Georgia expected to be impacted by Hurricane Helene, Verizon will waive postpaid domestic call/text/data usage from Sept. 26-Oct....

Continue reading

Qualigen Therapeutics, Inc. Announces management changes.

CARLSBAD, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced on September 23, 2024, Mr. Michael Poirier, notified the board of directors of the Company (the Board”) of his intention to resign as chief executive officer and Chairman of the Board of the Company, effective immediately. On the same date, Mr. Christopher Lotz, Chief Financial Office also tendered his resignation from the company, effective immediately. Both resignations were attributed to disagreements with the Company regarding its future direction and strategic initiatives. On September 25, 2024, the board of directors appointed Campbell Becher as President of the Company, effective immediately. On September 26, 2024, the board of directors appointed Kevin Richardson as Interim Chief Executive Officer...

Continue reading

CURRENC Rings Nasdaq Closing Bell in Honor of Listing

NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) — CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech and digital remittance pioneer serving millions of unbanked and underbanked individuals in Southeast Asia and beyond, today announced that the Company’s management celebrated its recent listing with a Closing Bell Ceremony at Nasdaq MarketSite in Times Square this afternoon. CURRENC began trading on the Nasdaq on September 3, 2024, after completing its business combination with INFINT Acquisition Corporation (formerly NYSE: IFIN), which was facilitated by ARC Group Limited. “Over the past decade, our digital remittance business has experienced rapid growth in both network coverage and total processing value, a testament to our team’s dedication and our customers’ trust,” said Alex Kong, Founder and Executive Chairman...

Continue reading

Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announced today that it has sold to a private investor 8,000 of the 1,015,008 shares it holds in TauRX Pharmaceuticals Ltd. (“TauRx”) at a price of US$125 per share for proceeds to the Company of US$1,000,000. The transaction remains subject to TauRx board approval. Following the completion of the transaction Dundee will continue to hold 1,007,008 TauRx shares. ABOUT DUNDEE CORPORATION Dundee Corporation is a public Canadian independent holding company, listed on the Toronto Stock Exchange under the symbol “DC.A”. Through its operating subsidiaries, Dundee Corporation is an active investor focused on delivering long-term, sustainable value as a trusted partner in the mining sector with more than 30 years of experience making accretive...

Continue reading

Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update

-Positive 90-day and 180-day Interim Clinical Trial Data for the First Oculopharyngeal Muscular Dystrophy (OPMD) Subject Dosed with the Low-Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study Reported in April and July- -Second Subject Dosed with the Low-Dose of BB-301 in February 2024, and Third Subject Expected to Receive the Low-Dose of BB-301 in Calendar Quarter Four of 2024- –Closed an Oversubscribed Private Placement Financing of $40.0 Million on April 22nd, Cash Runway Extended Through 2025– HAYWARD, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today...

Continue reading

Crediciorp Ltd.: Credicorp Highlights Growth Initiatives Driven by Innovation Strategy and Positive Outlook at the 2024 Strategic Update

On track to Achieve Sustainable 18% ROE Sets More Aggressive 2026 Aspirations for Yape Lima, Sept. 26, 2024 (GLOBE NEWSWIRE) — Lima, PERU, September 26, 2024 — Credicorp Ltd. today hosted its 2024 Strategic Update during which senior management outlined how the Company is powering sustainable growth through innovation, its goals and disciplined approach to digital disruption initiatives and the milestones achieved. Management also discussed the pipeline of future projects and how initiatives are serving to decouple its results from macroeconomic trends. Key highlights from the event include a reaffirmation of Credicorp’s commitment to innovation and self-disruption, market expansion, and shareholder value creation summarized below: Backed by strong performance across most of the Lines of Business, Credicorp remains on track...

Continue reading

Foxx Development Closes Business Combination with Acri Capital Acquisition Corporation and Will Begin Trading on Nasdaq

Business Combination between Foxx Development Inc. and Acri Capital Acquisition Corporation closed on September 26, 2024 Trading of common stock and warrants of the new public company, Foxx Development Holdings Inc., commence on Nasdaq on September 27, 2024 under the ticker symbols “FOXX” and “FOXXW”Austin, TX, Sept. 26, 2024 (GLOBE NEWSWIRE) — Foxx Development Holdings Inc. (Nasdaq: FOXX), a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients, today announced the successful closing of the previously announced business combination (“the Business Combination”) between Foxx Development Inc. (“Foxx”) and Acri Capital Acquisition Corporation (“Acri”), a publicly traded special purpose acquisition company. Acri stockholders approved...

Continue reading

Cue Biopharma Announces Proposed Public Offering

BOSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today announced that it is commencing an underwritten public offering of shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and accompanying warrants to purchase shares of common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. All of the securities are being offered by Cue Biopharma. Oppenheimer & Co. is acting as sole book-running manager for the offering. Newbridge Securities Corporation is acting as co-manager...

Continue reading

Wabash and Steel Dynamics Forge 10-Year Strategic Partnership

New agreement secures priority access to critical, domestic steel supplies, solidifying Wabash’s ability to meet growing industry demands LAFAYETTE, Ind., Sept. 26, 2024 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC), the visionary leader of connected solutions for the transportation, logistics and distribution industries, today announced a 10-year strategic agreement with Steel Dynamics, Inc., a leading steel producer and metal recycler in North America. This partnership will secure critical steel components, including hot-rolled, galvanized, and painted steel coils and steel crossmembers, to support Wabash’s extensive transportation solutions portfolio of van trailers, tank trailers, platform trailers and truck bodies. “We are excited to formalize our long-standing relationship with Steel Dynamics,” said Richard Mansilla, vice president,...

Continue reading

Costco Wholesale Corporation Reports Fourth Quarter and Fiscal Year 2024 Operating Results

ISSAQUAH, Wash., Sept. 26, 2024 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the 16-week fourth quarter and the 52-week fiscal year ended September 1, 2024. For the 16-week fourth quarter, the Company reported net sales of $78.2 billion, an increase of 1.0 percent compared to net sales of $77.4 billion in the 17-week fourth quarter of fiscal year 2023. For the 52-week fiscal year, the Company reported net sales of $249.6 billion, an increase of 5.0 percent from $237.7 billion reported in the 53-week fiscal year 2023. The following comparable sales data reflect comparable locations year-over-year and comparable retail weeks. Comparable sales were as follows:  16 Weeks   16 Weeks   52 Weeks   52 Weeks      Adjusted*       Adjusted*U.S. 5.3%   6.3%   4.5%   5.0%Canada 5.5%   7.9%   7.0%   8.1%Other...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.